Is this you? Create Your Porfile
Avatar

Andrew J. Schneider

Northwestern University

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Andrew J. Schneider is active.

Explore More

Publication

Featured researches published by Andrew J. Schneider.

Journal of Medicinal Chemistry | 2005

Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities.

Fortuna Haviv; Michael F. Bradley; Douglas M. Kalvin; Andrew J. Schneider; Donald J. Davidson; Sandra Majest; Laura M. Mckay; Catherine J. Haskell; Randy L. Bell; Bach Nguyen; Kennan C. Marsh; Bruce W. Surber; John Uchic; James L. Ferrero; Yi-Chun Wang; Juan Leal; Rae Record; Jason P. Hodde; Stephen F. Badylak; Richard R. Lesniewski; Jack Henkin

Biochemistry | 2003

Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese.

Jieyi Wang; George S. Sheppard; Pingping Lou; Megumi Kawai; Chang Park; David A. Egan; Andrew J. Schneider; Jennifer J. Bouska; Rick R. Lesniewski; Jack Henkin

Molecular Cancer Research | 2004

Peroxisome proliferator-activated receptor γ ligands improve the antitumor efficacy of thrombospondin peptide ABT510

Hanhua Huang; Steven C. Campbell; Dhugal F. Bedford; Thomas Nelius; Dorina Veliceasa; Emelyn H. Shroff; Jack Henkin; Andrew J. Schneider; Noel P. Bouck; Olga V. Volpert

Archive | 1999

Peptide antiangiogenic drugs

Jack Henkin; Fortuna Haviv; Michael F. Bradley; Douglas M. Kalvin; Andrew J. Schneider

Archive | 1999

Antiangiogenic drug to treat cancer, arthritis and retinopathy

Jack Henkin; Noel P. Bouck; David W. Dawson; Andrew J. Schneider

FEBS Journal | 1997

Plasminogen activation by pro-urokinase in complex with its receptor--dependence on a tripeptide (Spectrozyme plasmin).

Jieyi Wang; Andrew P. Mazar; Nancy Quan; Andrew J. Schneider; Jack Henkin

Archive | 2005

Substituted piperidines that have antiangiogenic activity

Fortuna Haviv; Michael F. Bradley; Andrew J. Schneider

Archive | 2002

Medicaments antiangiogeniques a base de peptides

Michael F. Bradley; Kalvin M. Douglas; Fortuna Haviv; Jack Henkin; Andrew J. Schneider

Archive | 2002

Peptid-antiangiogene arzneimittel

Jack Henkin; Fortuna Haviv; Michael F. Bradley; Kalvin M. Douglas; Andrew J. Schneider

Archive | 2000

Peptider, som har antiangiogen aktivitet

Michael F. Bradley; Fortuna Haviv; Jack Henkin; Douglas M. Kalvin; Andrew J. Schneider

Explore More

Collaboration

Dive into the Andrew J. Schneider's collaboration.

Top Co-Authors
Avatar

Jack Henkin

Northwestern University

View shared research outputs
Top Co-Authors
Avatar

Fortuna Haviv

TAP Pharmaceutical Products

View shared research outputs
Top Co-Authors
Avatar

Douglas M. Kalvin

University of Pittsburgh

View shared research outputs
Top Co-Authors
Avatar

Jieyi Wang

Ohio State University

View shared research outputs
Top Co-Authors
Avatar

Noel P. Bouck

Northwestern University

View shared research outputs
Top Co-Authors
Avatar

Andrew P. Mazar

Northwestern University

View shared research outputs
Top Co-Authors
Avatar

David W. Dawson

University of California

View shared research outputs
Top Co-Authors
Avatar

Dhugal F. Bedford

Northwestern University

View shared research outputs
Top Co-Authors
Avatar

Dorina Veliceasa

Northwestern University

View shared research outputs
Top Co-Authors
Avatar

Emelyn H. Shroff

Northwestern University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge